During the past decade, Aspire Health Partners conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
2011-04-01
2023-07-01
Active, not recruiting
1,545
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Aspire Health Partners"
#1 collaborator was "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator, "The Emmes Company, LLC" with 2 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "Harvard Medical School (HMS and HSDM)" with 1 trials as a collaborator and "Mclean Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Aspire Health Partners
According to Clinical.Site data, the most researched conditions in "Aspire Health Partners" are
"Opioid Use Disorder (OUD)" (1 trials) and "Opioid-use Disorder" (1 trials). Many other conditions were trialed in "Aspire Health Partners" in a lesser frequency.
Clinical Trials Intervention Types at Aspire Health Partners
Most popular intervention types in "Aspire Health Partners" are "Behavioral" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "MM" (1 trials), "MMD" (1 trials), "MMR" (1 trials), "Rapid Induction Procedure (RP)" (1 trials) and "SL-BUP" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Aspire Health Partners
The vast majority of trials in "Aspire Health Partners" are
2 trials for "All" genders.
Clinical Trials Status at Aspire Health Partners
Currently, there are NaN active trials in "Aspire Health Partners".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Aspire Health Partners,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Aspire Health Partners, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".